Company’s first offering, Ataraxis Breast, clinically validated in landmark study to be 30% more accurate than the current standard of care for breast cancer
$4 million in seed ...
2012, scientists Jennifer Doudna and Emmanuelle Charpentier published a seminal study describing a tool called CRISPR that could be used to make cuts in DNA. Since then, CRISPR research has taken ...
Scientists are harnessing the same technology behind the powerful gene-editing tool CRISPR to develop cheap devices that can quickly diagnose infections. These systems, described in new research, have the ...
CRISPR is already known for its power as a gene-editing tool that could one day transform how we fight cancer and other life-threatening diseases. But CRISPR’s potential is broader than that — ...